PACS Group (PACS) experienced a remarkable after-hours surge of 23.05% on Wednesday, building upon an already impressive 18.19% gain during the regular trading session. This significant uptick comes in the wake of the company's release of its third-quarter financial results and an optimistic outlook for the full year.

The healthcare operations company reported robust third-quarter figures, with quarterly sales reaching $1.345 billion, surpassing analyst estimates of $975.647 million by an impressive 37.86%. This represents a 31.09% increase compared to the same period last year. While the earnings per share of $0.32 slightly missed the consensus estimate of $0.33, it still marked a substantial 220% improvement from the previous year's $0.10 per share.

Investors were particularly encouraged by PACS Group's forward-looking statements. The company projects full-year revenue to be between $5.3 billion and $5.4 billion, with adjusted EBITDA expected in the range of $480 million to $490 million. Additionally, PACS Group announced the completion of a restatement of previous financial statements, bringing the company current with SEC filing obligations. This move likely bolstered investor confidence in the company's financial transparency and governance. The company's expansion strategy also appears to be gaining traction, with its portfolio now including 320 healthcare operations across 17 states, ownership of 51 facilities, and purchase options on an additional 59 facilities. PACS Group's commitment to growth through a combination of leasing, acquisitions, and evaluating opportunities in both high-performing and underperforming operations seems to have resonated strongly with investors, contributing to the significant after-hours stock price surge.